Trial Profile
Study of SCY-078 in patients with in patients with refractory invasive fungal infections
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2016
Price :
$35
*
At a glance
- Drugs Ibrexafungerp (Primary) ; Ibrexafungerp (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- 10 Aug 2016 New trial record
- 01 Aug 2016 According to Scynexis media release, this trial is expected to start by the end of 2016.